Premium
Onychomycosis in Children: A Brief Overview with Treatment Strategies
Author(s) -
Gupta Aditya K.,
Skinner Alayne R.
Publication year - 2004
Publication title -
pediatric dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 73
eISSN - 1525-1470
pISSN - 0736-8046
DOI - 10.1111/j.0736-8046.2004.21117.x
Subject(s) - terbinafine , itraconazole , medicine , fluconazole , dermatology , antifungal , nail (fastener) , nail disease , paronychia , materials science , metallurgy
Onychomycosis in children is uncommon. In those children that are affected, a family history of onychomycosis is not uncommon, giving importance to the examination of the entire family for fungal nail infections. In the United States, the newer oral antifungal agents itraconazole, fluconazole, and terbinafine, and the topical nail lacquers ciclopirox and amorolfine are not approved for this indication. More data are needed on the use of these antifungal agents for the treatment of onychomycosis in children.